Gabapentin is effective in the treatment of cancer-related neuropathic pain: a prospective, open-label study.

@article{Ross2005GabapentinIE,
  title={Gabapentin is effective in the treatment of cancer-related neuropathic pain: a prospective, open-label study.},
  author={Jennifer R. Ross and K. Goller and Janet Hazel Hardy and Judith A. Riley and Kathryn Broadley and RogerP. A'HERN and Jason D. Williams},
  journal={Journal of palliative medicine},
  year={2005},
  volume={8 6},
  pages={
          1118-26
        }
}
BACKGROUND Gabapentin has been evaluated in the treatment of nonmalignant neuropathic pain, however, there is little direct evidence evaluating its efficacy in cancer-related neuropathic pain. OBJECTIVE This study evaluated the effectiveness of gabapentin to treat cancer-related neuropathic pain. DESIGN This was an open-label study. Two parallel groups of patients were recruited with either treatment-related (radiotherapy, surgery, chemotherapy) or tumor-related neuropathic pain. Gabapentin… CONTINUE READING
BETA

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 31 CITATIONS

Similar Papers

Loading similar papers…